Shukra Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | BSE: 524632
₹233.40 
4.55 (1.99 %)
Last Updated: 01 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 233.35
High (₹) 233.40
Low (₹) 233.35
Prev. Close (₹) 228.85
Volume 54,117
VWAP (₹) 237.90
ROCE (%) 31.66
Industry P/E 46.23
TTM P/E 70.73
P/B Ratio 4.43
Market Cap (₹) Cr.1,022.01
Dividend Yield (%)0.43
EPS (₹) 16.93
ROE32.16%
Sales Growth (%) 26.75
Profit Growth (%)320.68
Day Range
233.40233.40
52 Week Range
35.73238.15
Historical Returns
Returns (6M)
221.05 %
Returns (1Y)
516.97 %
Returns (3Y)
6312.09 %
Returns (5Y)
8774.52 %
Returns (6M)
221.05 %
Returns (1Y)
516.97 %
Returns (3Y)
6312.09 %
Returns (5Y)
8774.52 %
SWOT Analysis
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BEARISHRSI 47.50
MFI 73.25
ATR 4.88
Commodity Channel Index 95.94
ROC125 181.32
ROC21 67.82
Williams %R -20.09
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 235.05 | 241.25 | 244.35 | 231.95 | 225.75 | 222.65 | 216.45 |
| Week Ago | 224.60 | 224.60 | 224.60 | 224.60 | 224.60 | 224.60 | 224.60 |
| Month Ago | 136.82 | 137.28 | 138.19 | 135.91 | 135.45 | 134.54 | 134.08 |
EMA & SMA
233.40
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 229.00
9 Day 221.65
10 Day 219.77
12 Day 214.11
14 Day 212.24
20 Day 196.55
26 Day 178.95
50 Day 127.25
100 Day 98.17
200 Day 95.52
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 29 Jan, 2025 | Stock split from Rs. 10/- to Re. 1/-. | 01 Jan, 1970 | 01 Jan, 1970 |
| 29 May, 2024 | Rs.1.0000 per share(10%)Final Dividend | 23 Sept, 2024 | 01 Jan, 1970 |
| 29 Feb, 2024 | Bonus issue in the ratio of 3:1 of Rs. 10/-. | 19 Apr, 2024 | 20 Apr, 2024 |
| 29 May, 2023 | Rs.0.5000 per share(5%)Final Dividend | 15 Sept, 2023 | 01 Jan, 1970 |
| 25 Aug, 2022 | Rights issue of equity shares of Rs. 10/- in the ratio of 6:1 @ premium of Rs. 10/-. | 02 Feb, 2023 | 02 Feb, 2023 |
| 30 May, 2022 | Rs.0.5000 per share(5%)Final Dividend | 22 Sept, 2022 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 29 Jan, 2025 | BSE India | Outcome of Board Meeting held today i.e. on January 29, 2025 pursuant to Regulation 30 of SEBI (Listing and Obligations and Disclosure Requirements) Regulations, 2015 |
| 24 Jan, 2025 | BSE India | Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 ,inter alia, to consider and approve Subdivision/ Stock Split of Equity Shares of the Company, subject to approval of the shareholders the Company and other necessary approvals |
| 04 Jan, 2025 | BSE India | Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2025 ,inter alia, to consider and approve To offer and issue of equity shares of the Company by way of a rights issue to eligible shareholders of the Company as on the record date (to be decided at a later date) for an amount not exceeding ? 36 crore in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws (the \Rights Issue\). |
| 29 Nov, 2024 | BSE India | Receipt of in-principal approval of Right Issue of equity shares of face value of Rs.10 each and issuing of amount aggregating not less than Rs.36,00,00,000. |
| 14 Nov, 2024 | BSE India | Un-audited Financial Results of the Company for the Second Quarter and Half Year ended on 30th September, 2024. |
| 14 Nov, 2024 | BSE India | Outcome of Board Meeting held today i.e. on 14th November, 2024 and submission of Un-audited Financial Results of the Company for the Second Quarter and Half Year ended on 30th September, 2024. |
| 07 Nov, 2024 | BSE India | Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Intimation of Board Meeting under Regulation 29 and 33 of SEBI (LODR) Regulations, 2015 to be held on Thursday, 14th November, 2024, To consider and approve the Un-audited Financial Results of the Company For the Second Quarter and half year ended on 30th September, 2024 ol the current F.Y 2024-25 pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015.\r\n |
| 25 Oct, 2024 | BSE India | Appointment of Sheetal Shah as Additional Promoter director and Ritu Kapoor as Additional Independent Director w.e.f. October 25, 2024. |
| 25 Oct, 2024 | BSE India | APPOINTMENT OF SHEETAL SHAH AS DIRECTOR AND RITU KAPOOR AS INDEPENDENT DIRECTOR IN THE MEETING HELD ON FRIDAY, OCTOBER 25, 2024. |
| 14 Oct, 2024 | BSE India | AGM conducted at the registered office of the company |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Stock Split | -- | 25 Jan, 2025 | 29 Jan, 2025 |
| Others | -- | 06 Jan, 2025 | 09 Jan, 2025 |
| Quarterly Results | -- | 08 Nov, 2024 | 14 Nov, 2024 |
| Rights issue of Equity Shares | -- | 25 Sept, 2024 | 28 Sept, 2024 |
| Quarterly Results | -- | 06 Aug, 2024 | 12 Aug, 2024 |
| Audited Results & Dividend | -- | 22 May, 2024 | 29 May, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 12 Feb, 2024 |
| Quarterly Results | -- | 30 Oct, 2023 | 08 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 12 Aug, 2023 |
| Audited Results & Final Dividend | -- | 22 May, 2023 | 29 May, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Shukra Pharmaceuticals
Shukra Pharmaceuticals is a Public Limited Listed company incorporated on 04/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ1993PLC019079 and registration number is 019079. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 74.57 Cr. and Equity Capital is Rs. 10.95 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1993
Managing Director
Mr. Dakshesh Rameshchandra Shah
NSE Symbol
--
Shukra Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Dakshesh Rameshchandra Shah | Managing Director |
| Mrs. Payal Sujay Mehta | Executive Director |
| Mr. Dhruvin Shah | Whole Time Director |
| Mr. Sanskruti Jayeshbhai Patel | Whole Time Director |
| Mrs. Anar Jayeshbhai Patel | Whole Time Director |
| Mrs. Bhoomiben Patel | Independent Director |
| Mrs. Sonal Deepalbhai Gandhi | Independent Director |
| Mr. Sarjeevan Singh Rathore | Independent Director |
| Mr. Jitendra Somchand Shah | Independent Director |
| Mrs. Pinki Nirmal Sagar | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,742.20  ₹1,743.95(-0.10%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,618.55  ₹5,577.70(0.73%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,439.50 ₹1,479.40(-2.70%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,481.60 ₹2,435.40(1.90%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,204.95 ₹1,217.35(-1.02%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Shukra Pharmaceuticals
What is the share price of Shukra Pharmaceuticals?
The share price of Shukra Pharmaceuticals on 01 Feb, 2025 is ₹ 233.40.
What is 52W high and 52W low share price of Shukra Pharmaceuticals?
The highest and lowest 52W share prices of Shukra Pharmaceuticals are ₹ 129.900 and ₹ 30.325
What is the market cap of Shukra Pharmaceuticals?
The market capitalization of Shukra Pharmaceuticals as of 01 Feb, 2025 is ₹ 1,022.01 Crores
What is the P/E ratio of Shukra Pharmaceuticals?
The current P/E ratio of Shukra Pharmaceuticals as of 01 Feb, 2025 is 46.23
What is the PB ratio of Shukra Pharmaceuticals?
The PB ratio of Shukra Pharmaceuticals as of 01 Feb, 2025 is 4.43
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)